Overview

A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic Schizophrenia

Status:
Completed
Trial end date:
1991-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the effectiveness and safety of different doses of risperidone (an antipsychotic medication) compared with a fixed 10-mg dose of a standard antipsychotic, haloperidol, in patients with chronic schizophrenia.
Phase:
Phase 3
Details
Lead Sponsor:
Janssen, LP
Treatments:
Haloperidol
Haloperidol decanoate
Risperidone